• Factors ID’d for Strong Antibody Response in COVID-19

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health October 26, 2020
  • COVID-19 Pandemic Challenges Osteoporosis Management

    Healthday News COVID-19, Family Practice, Geriatrics, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health October 26, 2020
  • AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy October 26, 2020
  • Survival From COVID-19 High in Patients With Psoriasis

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, Pharmacy October 23, 2020
  • FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say

    Healthday News COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy October 23, 2020

Sponsored by Janssen Pharmaceuticals, Inc. Intended for Healthcare Professionals

covid19.healthcare.pro
Navigation
  • COVID-19
  • Latest News
  • Travel Vaccine News
  • Influenza Vaccine News
  • Search
  • COVID-19
  • Latest News
  • Travel Vaccine News
  • Influenza Vaccine News
  • Search
Home Articles PRES

Tag Archive

  • COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health / October 26, 2020

    Factors ID’d for Strong Antibody Response in COVID-19

    View Post
  • COVID-19, Family Practice, Geriatrics, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health / October 26, 2020

    COVID-19 Pandemic Challenges Osteoporosis Management

    View Post
  • COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy / October 26, 2020

    AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials

    View Post
  • COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, Pharmacy / October 23, 2020

    Survival From COVID-19 High in Patients With Psoriasis

    View Post
  • COVID-19, Critical Care, Emergency Medicine, Family Practice, HealthDay News, Internal Medicine, Latest News, OBGYN & Women's Health, Pharmacy / October 23, 2020

    FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say

    View Post
View Post

Ivermectin Does Not Speed Symptom Resolution in Mild COVID-19

In COVID-19, Latest News
by Healthday
March 5, 2021

No significant improvement seen in median time to resolution of symptoms with ivermectin versus placebo

View Post

​IL-6 Receptor Antagonists Benefit Critically Ill With COVID-19​

In COVID-19, Latest News
by Healthday
March 2, 2021

Improved outcomes, including more organ support-free days, reduced mortality, seen with tocilizumab, sarilumab

View Post

Combination Monoclonal Antibody Treatment Authorized for COVID-19

In COVID-19, Latest News
by Healthday
February 10, 2021

EUA issued for combination of bamlanivimab and etesevimab in patients with mild-to-moderate COVID-19 at high risk for disease progression

View Post

Peginterferon Lambda Accelerates SARS-CoV-2 Decline in Outpatients

In COVID-19, Latest News
by Healthday
February 9, 2021

After controlling for baseline viral load, patients receiving peginterferon lambda significantly more likely to have undetectable viral load

View Post

Small Study Tests Colchicine for Moderate-to-Severe COVID-19

In COVID-19, Latest News
by Healthday
February 5, 2021

Authors call for larger clinical trials to further evaluate the efficacy and safety of colchicine as an adjunctive therapy for COVID-19

View Post

Metformin Use for T2DM May Reduce COVID-19 Mortality

In COVID-19, Latest News
by Healthday
January 27, 2021

Odds of contracting COVID-19, COVID-19-related mortality higher for individuals with diabetes

View Post

Adverse Drug Reactions Linked to Hydroxychloroquine Up in 2020

In COVID-19, Latest News
by Healthday
January 27, 2021

ADRs associated with hydroxychloroquine, chloroquine more than doubled in 2020 versus 2018 and 2019

View Post

COVID-19 Outcomes No Worse for Patients on Immunosuppressive Meds

In COVID-19, Latest News
by Healthday
January 26, 2021

Findings for ventilator use, length of stay, in-hospital mortality similar for those with, without chronic use of immunosuppressant agents

View Post

No Evidence Found to Support Discontinuing ACEIs, ARBs in COVID-19

In COVID-19, Latest News
by Healthday
January 26, 2021

Mean number of days alive and out of hospital not significantly different for those discontinuing, continuing meds

View Post

Bamlanivimab + Etesevimab Reduces SARS-CoV-2 Viral Load

In COVID-19, Latest News
by Healthday
January 22, 2021

No significant reduction seen in viral load at day 11 with bamlanivimab monotherapy in mild-to-moderate COVID-19

  • Page 1 of 4
  • 1
  • 2
  • 3
  • ...
  • 4
  • →

TRENDING

  • Is the COVID-19 Pandemic Fading Away?
  • A World With Fleeting Flu Cases
  • Ivermectin Does Not Speed Symptom Resolution in Mild COVID-19
  • Frequency of Urgent Vitreoretinal Surgery Down During Pandemic
  • Global Agreement Delivers Rotavirus Vaccine to Children

By Publish Date

March 2021
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
« Feb    

LATEST ARTICLES

  • Is the COVID-19 Pandemic Fading Away? March 5, 2021
  • A World With Fleeting Flu Cases March 5, 2021
  • Ivermectin Does Not Speed Symptom Resolution in Mild COVID-19 March 5, 2021

Sponsored by Janssen Pharmaceuticals, Inc. Intended for U.S. Healthcare Professionals.

Powered by eHealthcare Solutions. | Privacy Policy

  • COVID-19
  • Travel Vaccine News
  • Family Practice
  • OBGYN & Women’s Health
  • Clinical Guidelines